18:1 Biotinyl PE
Manufacturer: Sigma Aldrich
CAS Number: 384835-53-4
Synonym(S): 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine-N-(biotinyl) (sodium salt)
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| 25 MG | 870282C-25-MG | In Stock | ₹ 18,209.48 |
870282C - 25 MG
In Stock
Quantity
1
Base Price: ₹ 18,209.48
GST (18%): ₹ 3,277.706
Total Price: ₹ 21,487.186
form
liquid
packaging
pkg of 1 × 2.5 mL (870282C-25mg)pkg of 1 × 4 mL (870282C-100mg)pkg of 2 × 4 mL (870282C-200mg)
manufacturer/tradename
Avanti Polar Lipids 870282C
concentration
10 mg/mL (870282C-25mg)25 mg/mL (870282C-100mg)25 mg/mL (870282C-200mg)
shipped in
dry ice
storage temp.
−20°C
SMILES string
[H][C@@](COP([O-])(OCCN([H])C(CCCC[C@](SC[C@@]1(NC(N2)=O)[H])([C@]12[H])[H])=O)=O)(OC(CCCCCCC/C=C\CCCCCCCC)=O)COC(CCCCCCC/C=C\CCCCCCCC)=O.[Na+]
InChI
1S/C51H92N3O10PS.Na/c1-3-5-7-9-11-13-15-17-19-21-23-25-27-29-31-37-48(56)61-41-44(64-49(57)38-32-30-28-26-24-22-20-18-16-14-12-10-8-6-4-2)42-63-65(59,60)62-40-39-52-47(55)36-34-33-35-46-50-45(43-66-46)53-51(58)54-50;/h17-20,44-46,50H,3-16,21-43H2,1-2H3,(H,52,55)(H,59,60)(H2,53,54,58);/q;+1/p-1/b19-17-,20-18-;/t44-,45+,46+,50+;/m1./s1
InChI key
ZGFSYDGJPSEMJM-AOAFAMOJSA-M
Other Options
| Image | Product Name | Manufacturer | Price Range | |
|---|---|---|---|---|
 | eMolecules Broadpharm / 181 Biotinyl PE / 25mg / 718091972 / BP-28342 / 98.000 / 384835-53-4 / [null] / 992.320 / C51H91N3NaO10PS | eMolecules | ₹ 43,313.89 | |
| | Avanti Polar Lipids | 384835-53-4 | | 18 | Avanti Polar Lipids | ₹ 17,896.59 | |
 | 18:1 Biotinyl PE | Sigma Aldrich | ₹ 19,972.13 | |
 | 18:1 Biotinyl PE | ChemScene | ₹ 65,453.40 | |
 | 384835-53-4 | 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine-N-(biotinyl) (sodium salt) | A2B Chem | ₹ 36,191.88 |
Related Products
Description
- General description: 18:1 Biotinyl PE, also referred as 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine-N-(biotinyl), belongs to a class of head group modified functionalized lipids.
- Application: 18:1 Biotinyl PE is suitable: to tag N-glycolyl-monosialodihexosyl-ganglioside (NGcGM3) in the competitive assay[1], in preparation of small unilamellar vesicle[2], to test the functionalization of Polydimethylsiloxane (PDMS) polymer.[3]
- Packaging: 5 mL Clear Glass Sealed Ampule (870282C-100mg)
SAFETY INFORMATION
Pictograms
Signal Word
Danger
Hazard Statements
Precautionary Statements
P201 - P273 - P301 + P312 + P330 - P302 + P352 - P304 + P340 + P311 - P308 + P313
Hazard Classifications
Acute Tox. 3 Inhalation - Acute Tox. 4 Oral - Aquatic Chronic 3 - Carc. 2 - Eye Irrit. 2 - Repr. 2 - Skin Irrit. 2 - STOT RE 1 - STOT SE 3
Target Organs
Central nervous system, Liver,Kidney
WGK
WGK 3
Flash Point(F)
does not flash
Flash Point(C)
does not flash
Compare Similar Items
Show Difference
form: liquid
packaging: pkg of 1 × 2.5 mL (870282C-25mg)pkg of 1 × 4 mL (870282C-100mg)pkg of 2 × 4 mL (870282C-200mg)
manufacturer/tradename: Avanti Polar Lipids 870282C
concentration: 10 mg/mL (870282C-25mg)25 mg/mL (870282C-100mg)25 mg/mL (870282C-200mg)
shipped in: dry ice
storage temp.: −20°C
SMILES string: [H][C@@](COP([O-])(OCCN([H])C(CCCC[C@](SC[C@@]1(NC(N2)=O)[H])([C@]12[H])[H])=O)=O)(OC(CCCCCCC/C=C\CCCCCCCC)=O)COC(CCCCCCC/C=C\CCCCCCCC)=O.[Na+]
InChI: 1S/C51H92N3O10PS.Na/c1-3-5-7-9-11-13-15-17-19-21-23-25-27-29-31-37-48(56)61-41-44(64-49(57)38-32-30-28-26-24-22-20-18-16-14-12-10-8-6-4-2)42-63-65(59,60)62-40-39-52-47(55)36-34-33-35-46-50-45(43-66-46)53-51(58)54-50;/h17-20,44-46,50H,3-16,21-43H2,1-2H3,(H,52,55)(H,59,60)(H2,53,54,58);/q;+1/p-1/b19-17-,20-18-;/t44-,45+,46+,50+;/m1./s1
InChI key: ZGFSYDGJPSEMJM-AOAFAMOJSA-M
form: powder
packaging: pkg of 1 × 100 mg (870282P-100mg)pkg of 2 × 100 mg (870282P-200mg)pkg of 1 × 25 mg (870282P-25mg)
manufacturer/tradename: Avanti Polar Lipids 870282P
concentration: __
shipped in: dry ice
storage temp.: −20°C
SMILES string: [H][C@@](COP([O-])(OCCN([H])C(CCCC[C@](SC[C@@]1(NC(N2)=O)[H])([C@]12[H])[H])=O)=O)(OC(CCCCCCC/C=C\CCCCCCCC)=O)COC(CCCCCCC/C=C\CCCCCCCC)=O.[Na+]
InChI: 1S/C51H92N3O10PS.Na/c1-3-5-7-9-11-13-15-17-19-21-23-25-27-29-31-37-48(56)61-41-44(64-49(57)38-32-30-28-26-24-22-20-18-16-14-12-10-8-6-4-2)42-63-65(59,60)62-40-39-52-47(55)36-34-33-35-46-50-45(43-66-46)53-51(58)54-50;/h17-20,44-46,50H,3-16,21-43H2,1-2H3,(H,52,55)(H,59,60)(H2,53,54,58);/q;+1/p-1/b19-17-,20-18-;/t44-,45+,46+,50+;/m1./s1
InChI key: ZGFSYDGJPSEMJM-AOAFAMOJSA-M
form: powder
packaging: pkg of 1 × 100 mg (870285P-100mg)pkg of 1 × 200 mg (870285P-200mg)pkg of 1 × 25 mg (870285P-25mg)
manufacturer/tradename: Avanti Polar Lipids 870285P
concentration: __
shipped in: dry ice
storage temp.: −20°C
SMILES string: [H][C@@](COP([O-])(OCCN([H])C(CCCC[C@](SC[C@@]1(NC(N2)=O)[H])([C@]12[H])[H])=O)=O)(OC(CCCCCCCCCCCCCCC)=O)COC(CCCCCCCCCCCCCCC)=O.[Na+]
InChI: 1S/C47H88N3O10PS.Na/c1-3-5-7-9-11-13-15-17-19-21-23-25-27-33-44(52)57-37-40(60-45(53)34-28-26-24-22-20-18-16-14-12-10-8-6-4-2)38-59-61(55,56)58-36-35-48-43(51)32-30-29-31-42-46-41(39-62-42)49-47(54)50-46;/h40-42,46H,3-39H2,1-2H3,(H,48,51)(H,55,56)(H2,49,50,54);/q;+1/p-1/t40-,41+,42+,46+;/m1./s1
InChI key: ZBLHTNMJPDLJFU-DISIHPEUSA-M
